Briner V A, Williams B, Tsai P, Schrier R W
Department of Medicine, University of Colorado School of Medicine, Denver 80262.
Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2854-8. doi: 10.1073/pnas.89.7.2854.
The present study examines the binding and postbinding cellular processing and recycling of the V1 arginine vasopressin (AVP) receptor in cultured vascular smooth muscle cells (VSMCs). The surface binding of AVP to VSMCs was temperature dependent and reached equilibrium within 60 min at 4 degrees C. Displacement studies with unlabeled AVP or a specific V1 AVP antagonist revealed a single class of V1 receptors (Bmax, 1.99 pmol [corrected] per mg of protein; Kd, 2.15 nM). Incubation of VSMCs with unlabeled 10 nM AVP to promote receptor internalization resulted in a time- and temperature-dependent loss of AVP surface binding. At 37 degrees C, maximum loss of binding sites (65%) occurred within 20 min. Recovery of AVP binding occurred rapidly (t1/2, 15-20 min at room temperature) and was uninfluenced by inhibiting protein synthesis with cycloheximide. Pretreating VSMCs with chloroquine prevented AVP receptor recycling, indicating that the AVP-receptor complex requires endosomal processing. The biological competence of the recycled AVP receptor was shown by AVP-induced Ca2+ uptake. The results of these studies therefore indicate that, after surface binding, the AVP-receptor complex internalizes and dissociates in an endosomal compartment. It is demonstrated that in VSMCs biologically active V1 AVP receptors recycle back to the cell surface, thus attenuating the loss of AVP surface binding sites.
本研究检测了培养的血管平滑肌细胞(VSMC)中V1精氨酸加压素(AVP)受体的结合、结合后细胞加工及再循环情况。AVP与VSMC的表面结合具有温度依赖性,在4℃时60分钟内达到平衡。用未标记的AVP或特异性V1 AVP拮抗剂进行的置换研究显示存在单一类别的V1受体(Bmax,每毫克蛋白质1.99皮摩尔[校正后];Kd,2.15纳摩尔)。用未标记的10纳摩尔AVP孵育VSMC以促进受体内化,导致AVP表面结合呈时间和温度依赖性丧失。在37℃时,20分钟内结合位点最大丧失率为65%。AVP结合的恢复迅速(室温下t1/2为15 - 20分钟),且不受用放线菌酮抑制蛋白质合成的影响。用氯喹预处理VSMC可阻止AVP受体再循环,表明AVP - 受体复合物需要内体加工。再循环的AVP受体的生物学活性通过AVP诱导的Ca2 +摄取得以体现。因此,这些研究结果表明,在表面结合后,AVP - 受体复合物在内体区室内内化并解离。结果表明,在VSMC中具有生物活性的V1 AVP受体可再循环回到细胞表面,从而减弱AVP表面结合位点的丧失。